Best Fit Profiles
- short-window cognitive performance protocols
Acetylcholine support for memory and attention
Alpha-GPC
Early human trials show potential cognitive-performance support, but study quality and endpoint consistency remain heterogeneous.
Evidence Level B
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Modest attention and processing-speed support in selected cohorts
- Safety
- Moderate Risk
Can cause headaches, GI upset, or overstimulation in sensitive users.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 300-600 mg
- Timing
- Morning or 60-120 minutes before cognitive demand
- Protocol Duration in Studies
- 4-12 weeks in cognition-focused protocols
Dosing is typically individualized around acute performance windows and tolerance.